What is it about?
Progranulin (PGRN) plays important role in Gaucher disease. We developed a PGRN derivative can cross the blood brain barrier, penetrate to the brain tissue and rescue the neuropathic Gaucher disease and Parkinson’s disease phenotypes.
Photo by Lisa Yount on Unsplash
Why is it important?
There is no clinic drugs for treating neuropathic Gaucher disease because they cannot cross the blood brain barrier. The PGRN biologic which can cross blood brain barrier, and protects against neuropathic Gaucher disease and Parkinson’s disease phenotypes.
Read the Original
This page is a summary of: PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects,
mutation-associated pathologies and diseases, Proceedings of the National Academy of Sciences, December 2022, Proceedings of the National Academy of Sciences,
You can read the full text:
The following have contributed to this page